
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Nuveen Real Asset Income and Growth Fund remains rated Hold, given its focus on high-yield income and real asset exposure. JRI trades at a 4.77% discount to NAV, but this is less attractive than its three-year average discount of 7.23%. While JRI benefits from AI-driven infrastructure growth, its income-first strategy forces it to sell upside, limiting NAV appreciation.

Nuveen Real Asset Income and Growth Fund completed an oversubscribed 1-for-4 rights offering at $12.40 per share, raising approximately $108.5 million. The rights offering led to a 31.25% increase in share count and a NAV/share hit of -2.38% for existing holders. JRI's premium triggered the offering, but post-announcement discount widening made the event dilutive, reinforcing tactical "sell and rebuy" strategies.

The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 10% plus yield and 10.8% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.

CHICAGO--(BUSINESS WIRE)--Nuveen Real Asset Income and Growth Fund (NYSE: JRI) (the “Fund”) today announced the preliminary results of its transferable rights offering (the “Offer”) which expired at 5:00 p.m., Eastern time, on March 9, 2026 (the “Expiration Date”). The Offer entitled the rights holders to subscribe for an aggregate of up to an additional 7,000,000 common shares of the Fund (“Common Shares”). The Board has also approved a secondary over-subscription, whereby the Fund is authoriz.
